| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |